Rock Creek Pharmaceuticals, Inc. (RCPIQ) financial statements (2022 and earlier)

Company profile

Business Address 2040 WHITFIELD AVENUE
SARASOTA, FL 34243
State of Incorp. DE
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1855524931462,99391395
Cash and cash equivalents1855524931462,99391395
Receivables  62    
Prepaid expense      671
Disposal group, including discontinued operation 333556
Other undisclosed current assets9549485847964,2486,729
Total current assets:1941,1041,0439963,0944,3447,801
Noncurrent Assets
Property, plant and equipment147159170181192204207
Intangible assets, net (including goodwill)505255350367385402
Intangible assets, net (excluding goodwill)505255350367385402
Regulated entity, other noncurrent assets418426     
Restricted cash and investments10,88112,15717,295    
Disposal group, including discontinued operation, noncurrent assets24242424252425
Deferred costs  478    
Other undisclosed noncurrent assets6456482482482482482
Total noncurrent assets:11,58412,87418,5041,0371,0661,0951,116
TOTAL ASSETS:11,77813,97819,5472,0334,1605,4398,917
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,2589,0019,36012,64811,53917,34621,951
Accounts payable5,0685,6245,4755,9492,8364,3593,211
Accrued liabilities4,1903,3773,8854,2456,3009,5058,929
Employee-related liabilities   2,4542,4033,4823,132
Settlement liabilities      6,679
Debt12,35012,35012,350    
Due to related parties50505050505050
Disposal group, including discontinued operation365433433407415535533
Other undisclosed current liabilities   (1,925)(1,496)(3,482)(3,132)
Total current liabilities:22,02321,83422,19311,18010,50814,44919,402
Noncurrent Liabilities
Long-term debt and lease obligation2,7444,1708,000350350350350
Long-term debt, excluding current maturities2,7444,1708,000350350350350
Total noncurrent liabilities:2,7444,1708,000350350350350
Total liabilities:24,76726,00430,19311,53010,85814,79919,752
Stockholders' equity
Stockholders' equity attributable to parent(12,989)(12,026)(10,646)(9,497)(6,698)(9,360)(10,835)
Common stock152111119
Additional paid in capital302,418300,601299,290297,616297,574293,965292,028
Accumulated deficit(315,422)(312,629)(309,937)(307,114)(304,273)(303,326)(302,882)
Total stockholders' equity:(12,989)(12,026)(10,646)(9,497)(6,698)(9,360)(10,835)
TOTAL LIABILITIES AND EQUITY:11,77813,97819,5472,0334,1605,4398,917

Income statement (P&L) ($ in thousands)

6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
Revenues
(Financial Services Revenue)
  (242)3781,224  
Gross profit:  (242)3781,224  
Operating expenses(2,023)(1,361)(1,976)(3,496)(2,024)(3,819)(4,915)
Other undisclosed operating income (loss)  242(378)(1,224)  
Operating loss:(2,023)(1,361)(1,976)(3,496)(2,024)(3,819)(4,915)
Nonoperating income (expense)(772)(1,330)756287(13)3,522(230)
Other nonoperating income (expense)2111 287(13)3,522 
Interest and debt expense(793)(142)     
Other undisclosed loss from continuing operations before equity method investments, income taxes  (42)   (1)
Loss from continuing operations before equity method investments, income taxes:(3,588)(2,833)(1,262)(3,209)(2,037)(297)(5,146)
Other undisclosed income (loss) from continuing operations before income taxes  (1,560)3781,224 1
Loss from continuing operations:(3,588)(2,833)(2,822)(2,831)(813)(297)(5,145)
Loss from discontinued operations  (1)(10)  (4,404)
Net loss:(3,588)(2,833)(2,823)(2,841)(813)(297)(9,549)
Other undisclosed net income (loss) attributable to parent794141  (30)(41)3,610
Net loss available to common stockholders, diluted:(2,794)(2,692)(2,823)(2,841)(843)(338)(5,939)

Comprehensive Income ($ in thousands)

6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
Net loss:(3,588)(2,833)(2,823)(2,841)(813)(297)(9,549)
Comprehensive loss, net of tax, attributable to parent:(3,588)(2,833)(2,823)(2,841)(813)(297)(9,549)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: